Verified
来源、主体与时间与首次落库记录一致。
| 文章 | STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation |
| 信任等级 | Aggregate |
| 发布主体 | — |
| 来源 | https://www.statnews.com/2026/09/07/novo-nordisk-heart-studies-inflammation-ziltivekimab/?utm_campaign=rss |
| 创建时间 | Monday, 7 September 2026 - 19:33 |
| 已记录哈希 | 6a9ffa16a35d1214463ac728a86fbfaf67f640b3042d7d0a45e8f648636db78a |
| 重算哈希 | 6a9ffa16a35d1214463ac728a86fbfaf67f640b3042d7d0a45e8f648636db78a |
哈希算法：sha256(来源URL|主体ID|创建时间戳)，主体缺失时主体ID为 0。